Shanghai Haohai Biological Technology Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Haohai Biological Technology has a total shareholder equity of CN¥6.0B and total debt of CN¥423.7M, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are CN¥7.2B and CN¥1.2B respectively. Shanghai Haohai Biological Technology's EBIT is CN¥404.8M making its interest coverage ratio -6.4. It has cash and short-term investments of CN¥2.7B.
Key information
7.0%
Debt to equity ratio
CN¥423.70m
Debt
| Interest coverage ratio | -6.4x |
| Cash | CN¥2.69b |
| Equity | CN¥6.03b |
| Total liabilities | CN¥1.21b |
| Total assets | CN¥7.25b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5HB's short term assets (CN¥3.7B) exceed its short term liabilities (CN¥861.5M).
Long Term Liabilities: 5HB's short term assets (CN¥3.7B) exceed its long term liabilities (CN¥350.6M).
Debt to Equity History and Analysis
Debt Level: 5HB has more cash than its total debt.
Reducing Debt: 5HB's debt to equity ratio has increased from 0.7% to 7% over the past 5 years.
Debt Coverage: 5HB's debt is well covered by operating cash flow (159%).
Interest Coverage: 5HB earns more interest than it pays, so coverage of interest payments is not a concern.